Volver a la clasificación

Nordson Corporation (NDSN)

Valor Justo
IndustrialsSpecialty Industrial MachineryUnited States

Fundamental

71

Precio

$327.85

Capitalización Bursátil

$18.01B

Parte 1 · Cuánto vale la empresa

Resumen

Nordson makes precision dispensing equipment: machines that apply exact, controlled amounts of adhesives, coatings, sealants and other fluids inside a factory line, plus components used in medical devices and semiconductor manufacturing. Its products are typically a small line item inside a much larger production process — a diaper plant's glue applicator, a chip packaging step, a catheter's plastic tubing — but a failure or imprecision there can shut the whole line down.

Cómo genera ingresos

Revenue comes mostly from selling dispensing systems and components once, plus recurring sales of spare parts, nozzles and service that keep those systems running precisely over years of use. Because customers integrate Nordson's equipment into a validated production process, replacing it later requires re-qualifying the whole line, which supports steady repeat business rather than one-off equipment sales.

Ingresos por segmento

Industrial Precision Solutions48%

Adhesive, coating and sealant dispensing systems sold into packaging, general industrial and consumer goods production lines.

Medical and Fluid Solutions30%

Components and precision fluid-management systems used in medical devices such as catheters, plus fluid dispensing for other industries.

Advanced Technology Solutions22%

Equipment used in semiconductor and electronics manufacturing, including chip packaging and testing steps.

Ventaja competitiva

Costes de cambio · Estrecha

Once a customer validates a production line around Nordson's dispensing equipment — calibrated to exact fluid volumes and tolerances, sometimes under regulatory approval as in medical devices — swapping to a competitor means re-validating the whole line, a costly and slow process manufacturers avoid unless something is badly wrong. That keeps replacement parts and service revenue sticky even where the original equipment sale was competitive.

Qué impulsa la demanda

Moderadamente cíclico

Demand splits between steadier end markets — packaging, medical devices, consumer nondurables — and more cyclical ones like semiconductor and electronics capital spending, which swings with chip industry investment cycles. The mix of the three segments smooths some of that cyclicality but does not remove it, particularly in the Advanced Technology segment.

Riesgos clave

  • Cyclicality in semiconductor capital spending — The Advanced Technology Solutions segment depends on chip makers' capital equipment budgets, which are historically volatile and can swing sharply between shortage and oversupply periods.
  • Acquisition integration risk — Nordson has grown its segments partly through acquisitions; integrating acquired businesses' operations, systems and customer relationships carries execution risk and can strain expected returns.
  • Customer capital spending decisions — Equipment sales depend on customers deciding to build or upgrade production lines, decisions that can be postponed in an uncertain economic environment even when replacement parts demand continues.
  • International operations and currency exposure — A significant share of sales and manufacturing occurs outside the United States, exposing results to currency translation and to economic and trade conditions in those markets.

Los argumentos a favor

Buyers argue that Nordson's equipment gets embedded in validated production lines across three diversified end markets, that recurring parts and service revenue smooths the cycle, and that record fiscal 2025 results show the model compounding through both steadier and more cyclical segments at once.

Los argumentos en contra

Sellers fear that the Advanced Technology segment remains exposed to a genuinely volatile semiconductor capital-spending cycle, that growth built partly through acquisitions carries integration risk that can disappoint, and that a broader industrial slowdown would delay the equipment upgrades that drive the larger, steadier segments too.

Written by the editors, published on 18 de agosto de 2026

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Balance y Liquidez

Ingresos

$2.98B

Últimos 12 meses (hasta 31/7/2026)

Beneficio Neto

$555M

Últimos 12 meses (hasta 31/7/2026)

Flujo de Caja Libre

$661M

Patrimonio Neto Total

$3.04B

Pasivo Total

$2.87B

Ratio de Liquidez

1.82

Cobertura de Intereses

8.83

Deuda/EBITDA

2.30

Beneficio Por Acción

Ingresos y Beneficio Neto

Flujo de Caja Libre

Desglose de Ingresos

Estado histórico

Márgenes en el tiempo

La deuda en el tiempo

Cuánto pesa la deuda

Cuadro de crecimiento

Crecimiento — Ingresos

Estimación de Valor Justo

Caso generalValoración Justa

Valor Justo

$294.61

Precio Actual

$327.85

Margen de Seguridad

-11.3%

Rango de Valor Justo

$226.16 - $363.07

Dispersión entre los métodos de valoración utilizados, no un intervalo de confianza calibrado estadísticamente.

Métodos de Estimación

Precio objetivo de los analistas:$349.71
Flujo de caja descontado (DCF):$318.09
Múltiplo sobre beneficios (P/E):$246.87
Fórmula de crecimiento de Graham:$331.94
Valor de la capacidad de generar beneficios (EPV):$109.69
P/B justificado:$123.56
Descuento de dividendos (Gordon):$55.01
P/FFO, fondos de operaciones:$161.94
Beneficios de mitad de ciclo:$260.50
Múltiplo sobre ingresos:$151.25
Consenso de Analistas:Comprar (9B / 6H / 0S)
Última Sorpresa de Resultados:+2.66%

Métricas de Valoración

Ratio P/E

33.22

ROE

15.9%

Ratio P/B

5.59

P/FCF

25.22

Margen Bruto

55.3%

ROIC

12.1%

Radar de Rentabilidad

Creación de Valor (Ventaja Competitiva)

ROIC

12.1%

WACC

9.5%

ROIC − WACC

+2.6 pp

El ROIC supera el coste del capital: la empresa está creando valor para los accionistas.

Criterios de Análisis Fundamental

Superado (21)

  • EPS shows upward trend
  • EPS CAGR 5.49%
  • Price CAGR 11.11%
  • ROIC 12.1%
  • Gross Margin 55.3%
  • P/FCF 25.22
  • Debt/Equity ratio
  • Operating Margin 26.9%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 17.6%
  • Revenue Growth 5Y 5.7%
  • Analyst Consensus 60% Buy
  • Earnings Quality (OCF/NI) 1.39
  • Share Dilution -1.2%
  • Net Margin Trend 18.6% vs 16.3%
  • Piotroski F-Score 7/9

Fallido (6)

  • P/B Ratio 5.59
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Earnings Surprise avg 0.3%
  • PEG Ratio 2.18

No disponible (1)

  • Dividend Payout NaN%

Piotroski F-Score

7/9

Solidez financiera fuerte

score
criteria

Calidad de los Beneficios

1.39

Alta calidad: beneficios respaldados por efectivo

Dilución de Acciones

-1.2%

Recomprando acciones. Favorable para el accionista

Participaciones institucionales

Gobernanza

Equipo Directivo

NombreCargoEdad
Mr. Sundaram NagarajanPresident, CEO & Director62
Mr. Daniel R. HopgoodExecutive VP & CFO52
Ms. Jennifer L. McDonough J.D.Executive VP, General Counsel & Corporate Secretary53
Mr. Joseph P. KelleyExecutive VP of Industrial Precision Solutions Leader52
Mr. Joseph M. RutledgeVP & Chief Accounting Officer45
Ms. Lara L. MahoneyVice President of Investor Relations & Corporate Communications-
Katie ColacarroVice President of Corporate Development-
Ms. Sarah SiddiquiExecutive VP & Chief Human Resources Officer47
Mr. Justin HallExecutive Vice President of Medical & Fluid Solutions46
Mr. Matthew MatejkaSenior Director of Investor Relations-

Riesgo de Auditoría

8

Riesgo del Consejo

3

Riesgo de Compensación

6

Riesgo de Derechos del Accionista

10

Parte 2 · El precio y el momento de entrar

Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.

Documentos

  • Informe anual (10-K)

    Un resumen anual del negocio, los resultados financieros y los riesgos de la empresa.

    Presentado el 2025-12-17

    Ver documento
  • Informe trimestral (10-Q)

    Una actualización del desempeño financiero de los últimos tres meses.

    Presentado el 2026-08-20

    Ver documento
  • Informe de hecho relevante (8-K)

    Un aviso sobre un hecho relevante, como un cambio de dirección o un anuncio importante.

    Presentado el 2026-08-19

    Ver documento

via SEC EDGAR

Historial de Resultados

via SEC EDGAR

Latest News

Recent headlines for NDSN, sourced from Markets Gazette.

  • 8/21/2026POSITIVE
    Thursday’s Activity, 4 Possible Friday Plays

    Nordson Corporation (NDSN) was highlighted as a potential multi-bagger opportunity in Thursday's trading session, with the NDSN Weekly $310-320 call options showing significant upside potential. The article suggests that the stock has delivered strong performance, aligning with the firm's successful track record of identifying profitable trading plays. Investors who followed this recommendation may have seen substantial gains, indicating positive momentum for the company's stock.

via Markets Gazette